Trial intelligence / Profile preview

Corticoids for Empyema and Pleural Effusion in Children

NCT01261546Phase 2Completed

Sponsor
Hospital Universitario Infanta Sofía
Start
Dec 2010
Primary completion
May 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in parapneumonic pleural effusion and empyema comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Time to resolution of parapneumonic pleural effusion at 1 month. Started Dec 2010; status: completed.

02

Drugs

dexamethasone
03

Conditions

parapneumonic pleural effusionempyema

Beyond the preview

Go deeper on NCT01261546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01261546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call